Mobidiag Announces Release of Amplidiag® CarbaR+MCR, a Multiplex qPCR Test for Detection of Antibiotic Resistant Bacteria
4/19/18: “By obtaining the CE-IVD marking, the Amplidiag CarbaR+MCR test complement the currently available carbapenemases and resistances panel strengthening our commitment towards the fight against antibiotic resistance. Indeed Mobidiag has been using its expertise in the detection of gastrointestinal infections to combat multi-drug resistant organisms, a key application in our global strategy” said Tuomas Tenkanen, CEO at Mobidiag.
Mobidiag Announces Release of Amplidiag® Viral GE, a Multiplex PCR Test to Detect Gastrointestinal Viruses Directly from Stool Samples
Mobidiag Ltd, a Finnish molecular diagnostics company, today announced the CE-IVD marking of Amplidiag® Viral GE, a...